Found: 15
Select item for more details and to access through your institution.
Clinical and Serologic Phenotyping and Damage Indices in Patients With Systemic Lupus Erythematosus With and Without Fibromyalgia.
- Published in:
- ACR Open Rheumatology, 2024, v. 6, n. 4, p. 172, doi. 10.1002/acr2.11641
- By:
- Publication type:
- Article
Clinical outcomes after IL-6 blockade in patients with COVID-19 and HIV: a case series.
- Published in:
- AIDS Research & Therapy, 2022, v. 19, n. 1, p. 1, doi. 10.1186/s12981-022-00430-x
- By:
- Publication type:
- Article
Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23361-z
- By:
- Publication type:
- Article
Prevalence of concomitant rheumatologic diseases and autoantibody specificities among racial and ethnic groups in SLE patients.
- Published in:
- Frontiers in Epidemiology, 2024, p. 1, doi. 10.3389/fepid.2024.1334859
- By:
- Publication type:
- Article
Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis.
- Published in:
- Science Immunology, 2017, v. 2, n. 10, p. 1, doi. 10.1126/sciimmunol.aag3358
- By:
- Publication type:
- Article
High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines Partnership.
- Published in:
- Rheumatology, 2022, v. 61, n. 11, p. 4335, doi. 10.1093/rheumatology/keac067
- By:
- Publication type:
- Article
Neutrophil extracellular traps, B cells, and type I interferons contribute to immune dysregulation in hidradenitis suppurativa.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 508, p. 1, doi. 10.1126/scitranslmed.aav5908
- By:
- Publication type:
- Article
Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 7, p. e1964, doi. 10.1093/cid/ciaa1339
- By:
- Publication type:
- Article
Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 3, p. 459, doi. 10.1002/art.41518
- By:
- Publication type:
- Article
Leveraging the United States Epicenter to Provide Insights on COVID‐19 in Patients With Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 12, p. 1971, doi. 10.1002/art.41450
- By:
- Publication type:
- Article
Safety and Tolerability of Omalizumab: A Randomized Clinical Trial of Humanized Anti‐IgE Monoclonal Antibody in Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 7, p. 1135, doi. 10.1002/art.40828
- By:
- Publication type:
- Article
Citrullinated Aggrecan Epitopes as Targets of Autoreactive CD4+ T Cells in Patients With Rheumatoid Arthritis.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 4, p. 518, doi. 10.1002/art.40768
- By:
- Publication type:
- Article
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network.
- Published in:
- Arthritis Research & Therapy, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13075-024-03275-z
- By:
- Publication type:
- Article
Reply.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
RNA Externalized by Neutrophil Extracellular Traps Promotes Inflammatory Pathways in Endothelial Cells.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 12, p. 2282, doi. 10.1002/art.41796
- By:
- Publication type:
- Article